Comparative Analysis of Protein Quantification by the SomaScan Assay versus Orthogonal Methods in Urine from People with Diabetic Kidney Disease-Reference-Cited by-同舟云学术

Comparative Analysis of Protein Quantification by the SomaScan Assay versus Orthogonal Methods in Urine from People with Diabetic Kidney Disease

Published:2024-06-18 Issue:7 Volume:23 Page:2598-2607
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Lopez Lauren N.¹,Durbin-Johnson Blythe²,Vargas Chenoa R.¹,Ruzinski John³,Goodling Anne³,Mehrotra Rajnish³,Vaisar Tomas⁴,Rocke David M.²,Afkarian Maryam¹^ORCID

Affiliation:

1. Division of Nephrology, Department of Medicine, University of California, Davis, California 95616, United States

2. Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of California, Davis, California 95616, United States

3. Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington 98195, United States

4. Diabetes Institute, Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle,Washington98195,United States

Funder

National Center for Advancing Translational Sciences

National Cancer Institute

University of Washington

National Institute of Diabetes and Digestive and Kidney Diseases

Nora Eccles Treadwell Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.4c00322

Reference23 articles.

1. Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons

2. High-content affinity-based proteomics: unlocking protein biomarker discovery

3. Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery

4. Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy

5. Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes